Richard Letourneau
Montreal, QC H2X0C1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Oncological outcomes associated with primary-first, liver-first and synchronous resection strategies in synchronous colorectal liver metastases.
Journal: Surgical oncology
Published: April 27, 2026
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.
Journal: Oncoimmunology
Published: September 18, 2023
Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience.
Journal: Current oncology (Toronto, Ont.)
Published: March 12, 2021
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Journal: British journal of cancer
Published: January 28, 2021
Effect of intraoperative hypovolemic phlebotomy on transfusion and clinical outcomes in patients undergoing hepatectomy: a retrospective cohort study.
Journal: Canadian journal of anaesthesia = Journal canadien d'anesthesie
Published: October 30, 2020
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.
Journal: Current oncology (Toronto, Ont.)
Published: November 12, 2019
Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.
Journal: Oncoimmunology
Published: July 26, 2019
Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
Journal: International journal of surgery (London, England)
Published: August 27, 2018
Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.
Journal: Advances in therapy
Published: November 26, 2016
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.
Journal: Advances in therapy
Published: January 27, 2016
Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 18, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026